Back to Top Skip to main content Skip to sub-navigation

AFHSD’s GEIS collect data worldwide to support force protection

Image of Medical personnel scanning forehead of soldier with thermometer. Kuhina Talimalie, 735th Air Mobility Squadron, uses a no-touch thermometer on a U.S. Air Force airman to help mitigate the spread of COVID-19 among service members and the public. (Photo by Air Force Tech Sgt. Anthony Nelson Jr.)

Recommended Content:

Health Readiness | Public Health | Coronavirus | Environmental Exposures | Global Health Engagement | Armed Forces Health Surveillance Division | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

Throughout 2020, the Armed Forces Health Surveillance Division and its Global Emerging Infections Surveillance branch continued to work with partners across the globe in their efforts to combat COVID-19 and protect military readiness. That work goes on even as vaccines for the disease have begun to be administered.

“We continue to fund worldwide respiratory pathogen surveillance studies and COVID-19-specific projects to understand the burden of disease and collect strains from infected cases across the globe,” said Navy Capt. Guillermo Pimentel, Global Emerging Infections Surveillance (GEIS) branch chief. These studies “allow the DOD to conduct advanced characterization of this novel coronavirus and support public health authorities of partner host nations.”

These efforts have allowed the Department of Defense to collect “critical information” for force health protection, and have allowed GEIS surveillance projects to reach approximately 80 countries, with its “principal strength being these partnerships with allies and demonstration of a field presence in key geographic locations of military relevance,” Pimentel added.

The data collected from surveillance studies are being used to “initiate, as well as to further adjust or modify, regional infectious disease protection guidance to maintain our forces ready to carry out their mission in each respective combatant command’s area of responsibility,” the GEIS chief said.

GEIS is also funding respiratory pathogen surveillance projects that provide data related to the burden of respiratory diseases to U.S and host nation militaries.

GEIS continues to fund COVID-19 genomic sequencing efforts from DOD service members and foreign nationals, Pimentel said. These sequencing efforts are at DOD labs in Cambodia, Thailand, Peru, and Kenya. By going outside the continental U.S., GEIS is better able to track the spread and impact in support of the combatant commands.

GEIS partners have sequenced more than 350 novel coronavirus isolates and have provided sequencing support to “multiple outbreaks in the Navy and Army,” he noted.

The Armed Forces Health Surveillance Division and its branches also continue to monitor influenza and other major health events and outbreaks that are of military relevance. In connection with academic partners and the Defense Threat Reduction Agency, the Integrated Biosurveillance Branch has a near real-time mapping application called the Health Surveillance Explorer that can be used to better respond to seasonal or pandemic influenza viruses, “estimate their impact on the readiness of the force, plan personnel requirements and implement interventions,” said IBB Chief Juan Ubiera.

GEIS’s military partners in its sequencing and tracking efforts are the Army (Walter Reed Army Institute of Research, U.S. Army Medical Research Institute of Infectious Diseases), Navy (Navy Medical Research Center, Naval Health Research Center) and Air Force (U.S. Air Force School of Aerospace Medicine).

One partner from USAFSAM, Dr. Anthony Fries, a bioinformaticist from the Air Force Research Laboratory’s 711th Human Performance Wing at Wright-Patterson, Ohio, said the AFRL continues to increase the sequencing of SARS-CoV-2 viruses “to assess what viral diversity is circulating in our service members.” Fries noted his lab has sequenced more than 800 patients with COVID-19.

“While the impact and optimism surrounding vaccines cannot be overstated…we are positioning our sequencing activities to see how this virus responds to a population that will soon have robust protection to it from these new vaccines,” Fries said. “From an evolutionary perspective, we’re hoping that this virus’s limited ability to diversify itself could restrict its ability to avoid our efforts to stop it with the new vaccines.”

Air Force Maj. (Dr.) Jameson Voss, chief, Air Force Medical Service Precision Medicine, Air Force Medical Readiness Agency, added: “We need to understand the genetic changes in the virus to ensure diagnostic, vaccine, and other countermeasures are still working.”

You also may be interested in...

Memorandum on Providing Federal Support for Governors' Use of the National Guard to Respond to COVID-19

Publication
4/14/2020

Recommended Content:

Coronavirus

Delegation of Authority for Reserve Component Activation Authorities during the Coronavirus Disease 2019 Response

Publication
4/10/2020

This delegation assigns to the Service Secretaries the authority to activate Reserve Component personnel and to modify their orders as needed to employ and retain them for the COVID-19 response.

Recommended Content:

Coronavirus

Authorization to Employ Military Medical Capabilities to Treat COVID-19 Patients

Publication
4/8/2020

Effective immediately, the Commander, U.S Northern Command, is authorized, as he deems necessary and appropriate, to employ military medical capabilities under his operational control to treat patients who have contracted coronavirus disease 2019 (COVID-19).

Recommended Content:

Coronavirus

Decision Memorandum on TRICARE Implementation of the "Families First Coronavirus Response Act"

Publication
4/7/2020

The Families First Coronavirus Response Act, Public Law 116-127, Division F, Section 6006(a), limits TRICARE authority to impose copayment or other cost-sharing for novel coronavirus (COVID-19) testing and related provider visits that result in orders for or administration of Food and Drug Administration (FDA) approved, cleared, or authorized diagnostic products. In order for the Defense Health Agency (DHA) to implement, the Assistant Secretary of Defense for Health Affairs (ASD(HA)) must acknowledge the self-executing authority of the statute and direct the Director, DHA, or designee, to issue guidance implementing the statutory provisions.

Recommended Content:

About TRICARE | Coronavirus

DoD Guidance on the Use of Cloth Face Coverings

Publication
4/5/2020

Effective immediately, to the extent practical, all individuals on DoD property, installations, and facilities will wear cloth face coverings when they cannot maintain six feet of social distance in public areas or work centers (this does not include in a Service member's or Service family member's personal residence on a military installation).

Recommended Content:

Coronavirus | Public Health

Policy on Accessions and Accessions Training during the COVID-19 Outbreak

Publication
4/3/2020

The Military Departments must seek ways to maximize accessions in a responsible manner to minimize a reduction in military end strength and the potential deterioration of mid-and long-term readiness and capacity.

Recommended Content:

Coronavirus

Transition of Military Medical Treatment Facilities from Military Departments to the Defense Health Agency during the COVID-19 Response

Publication
4/2/2020

The Department's MTF transition plan is conditions-based. While the transition of MTFs to DHA is continuing, the COVID-19 response requirements are impacting DHA's ability to meet all required conditions. The need for the DHA and MILDEPs to refocus efforts away from the transition to support the COVID-19 response led to questions regarding the future of MTF Transition.

Recommended Content:

Coronavirus | Military Health System Transformation

Pharmacy Guidance for Market MTFs

Publication
3/31/2020

Message to Pharmacy Beneficiaries regarding military pharmacy services during the COVID-19 pandemic.

Recommended Content:

Coronavirus | TRICARE Pharmacy Operations | About TRICARE

Tiered Telehealth Health Care Support for COVID-19

Publication
3/31/2020

This memorandum establishes guidance for the use of Telehealth (TH) Information Technology (IT) tools in support of the clinical care required for patients across the spectrum of COVID-19 illness

Recommended Content:

About TRICARE | Public Health | Coronavirus

Q & A: Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Question and Answer: TRICARE Autism Care Demonstration (ACD): Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 during the COVID-19 National Emergency

Recommended Content:

Coronavirus | About TRICARE

Policy Exception for Telehealth Use for ABA during COVID-19 Pandemic

Publication
3/30/2020

Communication to ABA Providers Regarding Temporary Authorization to Utilize Telehealth for CPT Code 97156 During the COVID-19 National Emergency

Recommended Content:

Coronavirus | About TRICARE

COVID-19 Life Support Training Extension

Publication
3/19/2020

The purpose of this memorandum is to set policy guidance within the Military Health System for American Red Cross life support training (First Aid/cardiopulmonary resuscitation (CPR)/automated external defibrillator (AED), Basic Life Support (BLS), Advanced Life Support (ALS), and Pediatric Advanced Life Support (PALS)).

Recommended Content:

Coronavirus

Armed Forces Reportable Medical Events Guidelines and Case Definitions

Publication
1/1/2020

A reportable event may represent an inherent, significant threat to public health and military operation. These events have the potential to affect large numbers of people, to be widely transmitted within a population, to have severe/life threatening clinical manifestations, and to disrupt military training and deployment. Timely, accurate reporting of probable, suspected or confirmed cases ensures proper identification, treatment, control, and follow-up of cases.

Recommended Content:

Armed Forces Health Surveillance Division | AFHSD Reports and Publications

McCaffery AMSUS Remarks 2019

Publication
12/5/2019

McCaffery statements made during the 2019 annual meeting of AMSUS

Recommended Content:

Health Readiness

Increasing Partner-Nation Capacity Through Global Health Engagement

Publication
12/6/2017

GHE operations, activities, and actions (OAA) are used to implement the Secretary of Defense Policy Guidance for DoD GHE and the U.S. Army Medicine 2017 Campaign Plan in direct support of the U.S. Pacific Command (USPACOM) theater campaign plan (TCP) and U.S. Army Pacific (USARPAC) theater campaign support plan.

Recommended Content:

Global Health Engagement | Building Partner Capacity and Interoperability
<< < ... 6 7 > >> 
Showing results 76 - 90 Page 6 of 7
Refine your search
Last Updated: May 19, 2022

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.